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Abstract
The authors present two cases of primary sclerosing epithelioid fibrosarcoma (SEF) of the kidney. Both patients had
a mass in the upper part of the left kidney without any primary extrarenal neoplastic lesions. Grossly, the tumors
were solid masses both measuring 7.5 cm in the greatest diameter. Histologically, one of the lesions exhibited a
predominantly lobular growth of round or oval small uniform epithelioid cells in variable cellularity. Circular zones
of crowded tumor cells alternating with hypocellular collagenous tissue in a concentric fashion around entrapped
native renal tubules were distinctive. The second case was distinctive with significant cytological atypia in the
neoplastic cells and prominent reactive proliferations in the trapped renal tubules. Immunohistochemically,
vimentin, bcl-2 and MUC4 were diffusely positive in both. They were negative for S-100 protein, CD34, and desmin,
whereas CD99 were positive in one lesion. Fluorescence in situ hybridization assay using dual staining probes
detected EWSR1-CREB3L1 fusion in each lesion, which is characteristic molecular findings of SEF. One patient
presented widespread distant metastases at the time of diagnosis. In the other, no tumor deposits were detected
other than primary. Both patients have been alive with 30 and 10 month follow-ups, respectively. These tumors are
6th and 7th cases of primary renal SEF in the literature confirmed by FISH study, which exhibit unique and
remarkable histomorphologic features.
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Background
Sclerosing epithelioid fibrosarcoma (SEF) is a rare malig-
nant mesenchymal tumor of soft tissues composed of
cords, nests or sheets of relatively monotonous epithelioid
cells within a collagenous background. It has recently been
characterized by recurrent FUS-CREB3L1, FUS-CREB3L2
or EWS1-CREB3L1 translocations and immunohistochemi-
cal MUC4 expression [1–3]. The tumor occurs over a wide
age spectrum at initial presentation without sex predilec-
tion. Most reported cases are in the soft tissue of extrem-
ities and limb girdles [4–7]. Primary SEF in visceral organs
is exceedingly rare, with only a few cases reported.
Here, we present two cases of SEF with primary
renal origin bearing a EWS1-CREB3L1 gene fusion, as
supported by MUC4 immunostaining and fluorescence
in situ hybridization (FISH). To our knowledge, these
are the sixth and seventh genetically confirmed cases
of SEF reported in the kidney following very recently
described primary renal SEF(s) by Arbajian et al., Argani
et al. and Ohlmann, et al. [1, 8, 9]. Some of their morpho-
logic features are unique and deserve to be noted for full
characterization of this entity in a new environment.
Case presentation
Two cases of SEF that were found to harbor EWSR1-
CREB3L1 fusion were encountered in the diagnostic
practice of the authors. The clinical records were retrieved
for analysis, and all available pathologic materials were
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Immunohistochemistry
For immunohistochemical labeling, a polymer detection
system (Leica, DS9800) and the BOND-MAX automated
immunostainer was used. The standard antibodies con-
sumed, vendors, and dilutions were summarized in Table 1.
Fluorescence In Situ Hybridization (FISH)
FISH analysis was performed on representative 4–5 μm
thick unstained formalin-fixed, paraffin-embedded tissue
sections of the tumor samples of each case. For characte
rization of the possible underlying gene rearrangement
or fusion gene events, the following FISH probe sets
were utilized on both cases: Vysis LSI EWSR1 (22q12) and
Vysis LSI FUS (16p11) Dual Color Break Apart Probes
Table 1 Features of the antibodies used for the
immunohistochemical stains
Antigen Clone, dilution, source
Pan-Cytokeratin AE1/AE3, 1:200, Leica, Newcastle/UK
Epithelial Membrane Antigen E29, 1:300, Biocare, Concord/CA
PAX8 PAX8, 1:100, Biocare, Concord/CA
WT1 6 F-H2, 1:40, DBS, Pleasenton/CA
ER EP1, 1:100, Genemed, San Francisco/CA
PR SP2, 1:1000, Thermo, Fremont/CA
CD34 QBEND/10, 1:100, DBS, Pleasenton/CA
SMA 1A4, 1:1000, NeoMarkers, Fremont/CA
Desmin D33, 1:50, Biocare, Concord/CA
S100 protein Z0311, 1:6000, DAKO, Glostrup/Denmark
GFAP GA-5, 1:50, Thermo, Fremont/CA
Bcl2 Bcl-2-100, 1:80, Invitrogen, Paisley/UK
CD99 HO36-1.1, 1:100, Thermo, Fremont/CA
MUC4 1G8, 1:50, Invitrogen, Paisley/UK
HMB45 HMB45, 1:25, DBS, Pleasenton/CA
Melan-A A103, 1:100, Thermo, Fremont/CA
INI1 25, 1:50, Zeta, Arcadia/CA
Fig. 2 Case #1. Solid white tumor filling out the upper half of the kidney
Fig. 3 Case #1. Alternating hypercellular and a hypocellular areas of
neoplastic cells with monomorphic ovoid nuclei and indistinct pale
to clear cytoplasm (H&E x 200; inset: H&E x 400)
Fig. 1 Case #1. Computerized tomography scan showing a large tumor
in the left kidney
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(Abbott Molecular, Inc., Des Plaines, IL) and EWSR1 and
CREB3L1 spanning probe sets using cocktails of BAC
clones (RP11-945 M21 and RP11-1126O13, and RP11-
1014A16, RP11-1106 J11 and RP11-481I24 respectively)
selected on the basis of their location per the UCSC
Human Genome Browser [http://genome.ucsc.edu/cgi-
bin/hgGateway] and obtained from BAC/PAC Re-
sources Center (Children’s Hospital Oakland Research
Institute, Oakland, CA, USA).
Hybridization studies using the Vysis LSI Dual Color
Break Apart Probes for the assessment of rearrangement of
the FUS and EWSR1 loci were performed following the
manufacturer’s instructions (Abbott Molecular, Inc., Des
Plaines, IL). With respect to the custom spanning probes,
each BAC clone was directly labeled by nick translation
with either Spectrum Green- or Spectrum Orange-dUTP
per the manufacturer’s protocol (Abbott Molecular, Inc.,
Des Plaines, IL). An amount of 3 ug of DNA for each
probe or 1.5 ug for each of two probes were combined.
All nick translation reagents were then multiplied by
the total ug of DNA used in the cocktail. Amounts of
200 ng of each probe were hybridized to the target
DNA and blocked with approximately 15 fold excess
of a combination of Human Cot-I DNA (Invitrogen,
Carlsbad, CA) and human placental DNA.
Prior to hybridization, the slides were pretreated at
room temperature in 0.2 N HCl for 20 min, washed in
water for 3 min, incubated at 80 °C for 25 min in VP
2000 Pretreatment Reagent (Abbott Molecular, Inc., Des
Plaines, IL) and then washed again in water for 3 min.
Subsequently, the slides were incubated for 15 min at 37 °C
in protease solution [25 mg of protease in 50 ml of protease
solution (Abbott Molecular, Inc., Des Plaines, IL), washed
in 1 × PBS at room temperature for 5 min and then dehy-
drated in gradient ethanol (75, 85, and 100 %) at room
temperature for 1 min each and air-dried. After the cells
and probes were co-denatured at 80 °C for 10 min and
incubated overnight at 37 °C using the HYBrite™ system
(Abbott Molecular, Inc., Des Plaines, IL), post-hybridization
washing was performed in 2 × SSC/0.1 % NP-40 at 72 °C
for 2 min, followed by 2 × SSC/0.1 % NP-40 at room
temperature for 1 min. The slides were then counter-
stained with DAPI II (Abbott Molecular, Inc., Des Plaines,
IL). To confirm correct mapping, optimal signal strength,
and lack of cross-hybridization, each probe set was also
hybridized to metaphase cell preparations of karyotypically
normal peripheral blood lymphocytes before proceeding
with analysis of the patient samples.
The cutoff level for scoring a specimen as positive for a
rearrangement of the FUS or EWSR1 locus or as positive
for an EWSR1/CREB3L1 fusion was >15 % of the cells eval-
uated. Images were prepared using the Cytovision Image
Analysis System (Applied Imaging, Santa Clara, CA). For
each probe set, 100–200 interphase nuclei with strong and
well-delineated signals were examined.
Case 1
The patient was a 16-year-old girl who presented at
the urology clinics with pain on the left side of the abdo-
men radiating to the back. Her past medical history was
Fig. 4 Case #1. a Lobular/micronodular pattern (H&E x 40). b Concentric hypocellular inner, hypercellular outer zone around entrapped renal
tubules (H&E x 100)
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insignificant. Computerized axial tomography scans of the
chest, abdomen, and pelvis revealed a 70 × 70 × 60 mm left
renal mass (Fig. 1), bilateral pulmonary nodules (the
largest being 16 mm in diameter), and widespread bone
metastases in vertebrae, sacrum and left femoral head. A
biopsy from the tumor in the kidney through laparotomy
was performed followed by left radical nephrectomy after
the diagnosis of malignancy.
Tumor occupied the entire upper half of the kidney,
extended into the renal sinus, was a solid white unencapsu-
lated lesion with sharp borders, measuring 7.5 × 7 × 7 cm in
size (Fig. 2). Microscopical sections showed diffuse infiltra-
tion of the neoplastic tissue in kidney parenchyma separat-
ing normal renal elements from each other. The neoplastic
cells were small, monotonous and epithelioid with clear to
pale eosinophilic cytoplasm, and were arranged in single
files, cords, nests or irregular aggregates in collagenous
matrix (Fig. 3). Nuclei were generally round to oval, with
indistinct nucleoli. Hypercellular areas alternated randomly
with hypocellular densely hyalinized or at times myxoid
stroma. Additionally, a peculiar lobular organization was
noted in many regions where a renal tubule in the center
was surrounded by concentric inner hypo and outer
hypercellular zones of neoplastic cells (Fig. 4a and b).
These lobules were separated from each other by myo-
fibroblasts. Tubules entrapped in the tumor were lined
by single layered Pax-8 positive cuboidal cells without
atypia, some showed shallow papillary hyperplasia and
rare mitosis. Mitotic rate was 1/10 hpf in the neoplasm
and there were occasional areas of necrosis in the tumor.
Hypercellular areas occasionally contained vague nodules
of collagen mimicking those seen in hyalinizing spindle cell
tumor with giant rosettes (HSCTGR). The surrounding
kidney showed no specific pathologic changes. By im-
munohistochemistry, neoplastic cells were immunore-
active diffusely and strongly for vimentin, bcl-2 and CD99;
EMA labelled them in a weak and patchy fashion (Fig. 5).
They were negative for pan-cytokeratin, Pax-8, WT-1,
CD34, S-100, GFAP, Melan-A, HMB-45, desmin, and
estrogen and progesterone receptors. Smooth muscle
actin (SMA) stained myofibroblastic cells in-between the
neoplastic lobules (Fig. 6). INI-1 was preserved. Then, an
Fig. 5 Case #1. Strong bcl-2 and weak EMA expression by neoplastic cells (Left: Immunohistochemistry, anti-bcl-2 Ab x 200; Right: Immunohistochemistry,
anti-EMA Ab x 200)
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immunohistochemical stain for MUC4 was performed
which showed strong positivity throughout the tumor
(Fig. 6). Finally, FISH analysis with the EWSR1 Break
Apart probe revealed loss of one copy of the Spectrum
Green labeled probe flanking the 3’ (telomeric) side of the
EWSR1 gene as well as the presence of a single fused
EWSR1/CREB3L1 signal (represented by a juxtaposed or-
ange signal and green signal) consistent with the presence
of an unbalanced der(22)t(11;22)(p11;q12) (Fig. 7), con-
firming the diagnosis of sclerosing epithelioid fibrosar-
coma. FISH study was negative for a rearrangement of the
FUS gene locus.
Patient was given chemotherapy with multiple agents.
She is alive with disease after 30 month follow-up.
Case 2
The patient was a 57-year-old woman who was investigated
for cholelithiasis due to dyspeptic complaints. During ab-
dominal ultrasonography, she was found to have a left renal
mass incidentally. The CT scan showed that the tumor was
located at the upper pole of the kidney and was measured
6 cm in the largest diameter. Her past medical history was
unremarkable except for hypertension, congestive heart fail-
ure and arrhythmia. Serum and urine tests were within the
normal limits. The patient subsequently underwent open
left partial nephrectomy.
On gross examination, the specimen had an unencap-
sulated, solid - white firm tumor with irregular borders,
measuring 7.5 × 5.5 × 4 cm (Fig. 8). Histologic examin-
ation revealed that tumor contained abundant entrapped
native renal tubules throughout as in the first case, mim-
icking a biphasic neoplasm (Fig. 9). These tubules were
hyperplastic and proliferating, were of various size and
shapes, some being cystic or leaf-like, and lined by single
layered cuboidal or occasionally flattened cells, all express-
ing nuclear Pax-8. Intraluminal papillary projections were
common, but without cytologic atypia. Neoplastic compo-
nent had a variable cellularity (Fig. 10). Hypocellular re-
gions contained abundant hyalinized collagen and some
showed myxoid change. Hypercellular areas were divided
into anastomosing compartments by sclerotic collagen
bands. Neoplastic cells were polygonal epithelioid or plump
Fig. 6 Case #1. SMA stains myofibroblasts between neoplastic lobules and MUC4 stains neoplastic cells (Left: Immunohistochemistry, anti-SMA Ab x 100;
Right: Immunohistochemistry, anti-MUC4 Ab x 400)
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spindle type forming short fascicles (Fig. 11). Cytoplasm
was clear or eosinophilic. Cellular pleomorphism was
prominent with scattered bizarre and hyperchromatic
nuclei, intranuclear inclusions were evident in some.
Tumor abutted lining urothelium of renal pelvis with-
out ulceration and formed large hypocellular sheets of
short spindle cells in myxoid matrix encircling pelvic wall.
There were rare foci of necrosis. Mitotic rate ranged 5–10/
10 hpf. Immunohistochemical profile of tumor was similar
to the first case including strong and diffuse MUC4, vimen-
tin and bcl-2, weak EMA expression (Fig. 12) except nega-
tive immunoreactivity for CD99. SMA showed frequently
scattered myofibroblasts between the tumor cells. FISH
demonstrated an unbalanced der(22)t(11;22)(p11;q12), as in
the case #1 (Fig. 13). A FUS gene rearrangement was not
identified.
The lesion occupied both renal cortex and medulla, and
invaded into peripelvic and perirenal fat tissue. As one of
the surgical margins was in continuation with the tumor,
the patient underwent left radical nephrectomy which
showed 1 cm residual mass. No adjuvant treatment was
given. Patient is alive without local or distant recurrence
10 months after surgery.
Discussion
Sclerosing epithelioid fibrosarcoma (SEF) was first de-
scribed by Meis-Kindblom et al. in 1995 [6]. The most
SEFs are deep seated lesions with a wide age range, but
typically occurring in middle aged adults [4, 6]. The
most frequent sites of involvement are deep soft tissues
of lower extremities or limb girdle followed by trunk,
upper extremities, and head and neck region, although
primary SEF of unexpected locations such as bone, retro-
peritoneum, and pelvis were also described as case reports
or small series [10–13]. Primary SEF in visceral organs is
exceedingly rare, with only a single case reports in the liver
[12], the lower gastrointestinal tract [11], the ovary [14],
and the pancreas [10]. Occurrence of primary renal SEF
was proven by Argani et al. who have recently reported 2
well-documented cases with rearrangement involving
Fig. 7 Case #1. An EWSR1 Break Apart probe set and a custom probe set spanning the EWSR1 (Spectrum Orange) and the CREB3L1 (Spectrum Green)
loci demonstrating loss of the Spectrum Green labeled probe signal that flanks the 3’ (telomeric) side of the EWSR1 locus (short arrows, left panel) and
a single fusion signal (long arrows, right panel)
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EWSR1 and CREB3L1 genes [8] (Table 2). There are also 3
additional cases in the literature described as primary renal
SEFs which were shown to express MUC4 [1, 9]. Two of
these had rearranged EWSR1 with undocumented fusion
gene partner.
SEF is a difficult diagnosis in visceral organs because of
its rarity and its epithelioid appearance, closely mimicking
carcinomas. It is characterized by a proliferation of epitheli-
oid cells arranged in nests and cords in a densely hyalinized
stroma (Table 3). Neoplastic cells are positive for vimentin,
bcl-2, MUC4, weakly and focally for epithelial membrane
antigen (EMA), and are negative for broad spectrum cyto-
keratins, smooth muscle actin, desmin, CD34, S-100 pro-
tein, HMB45 and melan-A [2, 4, 15]. MUC4 itself has
been recently reported as highly specific for the diagnosis
of SEF [2]. Strong CD99 expression is seen in some cases.
Most common genetic alteration described in pure SEFs is
EWSR1-CREB3L1 fusion [1]. Basic histomorphological
differentials of SEF will be a variety of tumors with epithe-
lioid and sclerotic features, mainly primary or metastatic
carcinoma. Epithelioid angiomyolipoma, metanephric stro-
mal tumor and synovial sarcoma are the other consider-
ations in the differential diagnosis, as well as sclerosing
clear cell sarcoma of the kidney (CCSK) being the most
challenging. A battery of immunohistochemical stains will
help for further characterization in most circumstances,
Fig. 8 Case #2. Gross photograph of the kidney in patient no. 2
shows a well-defined solid mass that extends to surgical margin
of the partial nephrectomy specimen
Fig. 9 Case #2. Proliferating native renal tubules inside the tumor giving an appearance of a biphasic lesion (H&E x 100). Inset shows that hyperplastic
tubules maintain nuclear pax-8 (H&E x 40)
Ertoy Baydar et al. Diagnostic Pathology  (2015) 10:186 Page 7 of 12
however SEF and sclerosing type CCSK reveal both similar
morphology and immunohistochemical findings Argani et
al. suggest that some cases reported as sclerosing clear cell
sarcoma of the kidney (CCSK) in the literature might in
fact represent SEF [8].
SEF and low-grade fibromyxoid sarcoma (LGFMS) are
thought to be related members in the fibrosing fibrosar-
coma family [4]. Classic variants of LGFMS with or without
giant rosettes constitute one end of the spectrum, charac-
terized by a protracted clinical course and a low metastatic
rate, whereas SEF or cellular variants of LGFMS constitute
the other end which appears to be more aggressive. LGFMS
may have SEF-like areas, and vice versa occurs in SEF
lesions. Both tumors are labelled by immunohistochemical
MUC4 staining, 99–100 % in LGFMS and 78 % in SEF,
respectively [2, 16]. Furthermore, a genetic link between
sclerosing epithelioid fibrosarcoma and low-grade fibro-
myxoid sarcoma has been suggested [17]. Although major-
ity (>90 %) of LGFMS and hybrid LGFMS/SEF harbor
t(7;16)(q33;p11) chromosome translocation resulting in
FUS-CREB3L2 gene fusion, rare LGFMS carrying EWSR1-
CREB3L1 gene fusion with t(11;22)(p11;q12) chromosome
translocation was also found [18]. There have been 5 cases
of primary LGFMS described in kidney or renal pelvis so
far, one in a 6 year old child, others in adults [19–23].
We report 2 distinctive, clinically malignant, renal SEF
bearing EWSR1-CREB3L1 fusions through unbalanced
translocation with unique histomorphologic features.
The common finding in both was the diffuse infiltration
of the tumor among renal tubules and glomeruli filling
out the space in-between them. Numerous tubules and
also glomeruli were seen entrapped throughout the
tumors. In case #1, neoplastic cells surrounded these
tubules in a concentric onion-skin like pattern giving a
lobular or micronodular architecture to the lesion in
many areas. Additionally, the neoplastic sleeves around
tubules revealed a zonation pattern with inner hypo-
cellular and outer hypercellular appearance. This was a
wide-spread occurrence involving also the deeper parts
of the tumor, so differed from what is seen in CCSK or
metanephric stromal tumor where neoplasm encircles
native tubules at the tumor infiltration borders in a
Fig. 10 Case #2. Hyper and hypocellular regions (Left: H&E x 200; Right: H&E x 200)
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limited extent. No angiodysplasia or juxtaglomerular
hyperplasia was found in our case.
The second case presented in this study varied from
the first one in that the entrapped renal tubules exhib-
ited prominent papillary hyperplasia and small gland
budding which gave a biphasic appearance to the
lesion. They were lined by cuboidal or flattened single
layered epithelium devoid of atypia, some were cystic,
and some looked fibroadenomatous and leaf-like due
to compression by the interstitial neoplastic cells. It is
quite likely that we would have diagnosed this lesion
as malignant mixed epithelial and stromal tumor of
kidney (MEST) only a few years ago when typical genetic
alterations or MUC4 staining characteristic of this tumor
type were unknown yet. In fact, we suspect that other
examples of renal SEF may have been reported in the lit-
erature with an assignment as malignant MEST. Suzuki et
al. [24] reported a malignant MEST in a male with a pros-
tatic adenocarcinoma under anti-androgen treatment, that
was composed of atypical small round cells with a high
nuclear cytoplasmic ratio without necrosis and pleo-
morphism, and also focal spindle cells without cytologic
atypia in a gradual transition to small round cells. Immu-
nohistochemically, tumor was bcl-2 and CD99+, SMA
and S-100 -. SYT-SSX1 and SYT-SSX2 chimeric transcript
were not identified. We suspect that at least this published
case may represent the entity reported herein.
Another feature of the second case of this study that var-
ied from the first one and from 5 cases reported previously
was the presence of high grade cytologic atypia with note-
worthy pleomorphism and scattered bizarre tumor cells.
Most SEFs are cytologically uniform tumors with scanty
mitoses; however, it is stated that foci of pleomorphism
-particularly in hybrid SEF and LGFMS cases- and high
mitotic activity can rarely be encountered [4, 7, 17].
SEF is frequently characterized by aggressive clinical
behavior [4, 6]. One or more local recurrences occur in
approximately 50 % of cases, with metastatic spread being
reported in more than 40 % of cases, most often affecting
the pleura, lungs, bone and central nervous system. All of
the cases reported previously except one and our first case
were already metastatic at the time of presentation. As
accurate recognition of SEF is important for appropriate
patient management, we believe more cases need to be
Fig. 11 Case #2. Spindle cells forming short fascicles vaguely (H-E x 200). Inset highlights marked pleomorphism among the neoplastic cells (H-E x 400)
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Fig. 12 Case #2. SMA stains interspersed myofibroblasts and MUC4 labels neoplastic cells (Left: Immunohistochemistry, anti-SMA Ab x 200; Right:
Immunohistochemistry, anti-MUC4 Ab x 200)
Fig. 13 Case #2. FISH patterns similar to Case 1. EWSR1 break apart with loss of one copy of the Spectrum Green labeled probe flanking
the 3’ (telomeric) side (left panel) and EWSR1/CREB3L1 fusion seen by a juxtaposed orange signal and green signal (right panel)
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documented so that its full histomorphologic spectrum is
uncovered.
Conclusions
Sclerosing epithelioid fibrosarcoma (SEF) is a rare soft
tissue tumor that can occur in the kidney as a primary
malignancy. Its misdiagnosis with other entities which
are better known to develop in the kidney is a strong
possibility as it has been only recently described and is
unfamiliar to the pathologists. SEF is a neoplasm with
variant morphological features that may overlap with
many lesions confusingly. Immunohistochemistry and
molecular studies that disclose the characteristic genetic
alterations are crucial for accurate recognition.
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NS Not specified, L Left kidney, R Right kidney, RT Radiotherapy, CT chemotherapy, RCT Radiochemotherapy, DOD Died of disease, DOC Died of complications
related to disease treatment, AWD Alive with disease, ANED Alive with no evidence of disease
Table 3 Morphology of SEF
Typical features
Macroscopy Large, homogeneously white or white–tan, lobulated, and hard tumors
Cell size and shape Small to medium-sized plump to epithelioid cells
Cytoplasm Scant clear or eosinophilic cytoplasm
Nuclei Oval to slightly elongate angulated nuclei with finely speckled chromatin
Cellularity Variable within the neoplasm
Atypia Mild
Matrix Densely sclerotic, areas of metaplastic bone in some
Pattern of cellular arrangement Small clusters, nests and anastomosing cords
Hybrid morphology Areas of LGFMS or nodules of collagen reminiscent of HSCTGR in some
Immunohistochemistry MUC4 ++, EMA +/−, CD99 +/−, bcl2 +/−, pan-keratin -, S100/HMB45/MelanA -
FISH EWSR1 (or rarely FUS) rearrangements
Previously unrecognized features in renal SEF
Current case 1 A lobular or micronodular architecture due to neoplastic cells surrounding entrapped renal tubules in a concentric fashion
Zonation in the neoplastic lobules around tubules with inner hypocellular and outer hypercellular appearance
Current case 2 Exuberant epithelial hyperplasia and small gland budding in the entrapped native renal tubules, mimicking MEST
High grade cytologic atypia
LGFMS Low grade of fibromyxoid sarcoma, HSCTGR Hyalinizing spindle cell tumor with giant rosettes, MEST Mixed epithelial and stromal tumor of kidney
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Case Report and any accompanying images. A copy of the
written consent is available for review by the Editor-in-
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